<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4B8017E5-40E0-4ED8-9216-7010746F9003"><gtr:id>4B8017E5-40E0-4ED8-9216-7010746F9003</gtr:id><gtr:name>Institute of Cancer Research UK</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4B8017E5-40E0-4ED8-9216-7010746F9003"><gtr:id>4B8017E5-40E0-4ED8-9216-7010746F9003</gtr:id><gtr:name>Institute of Cancer Research UK</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A4B75635-B5CA-4813-867C-E1A3FF17C446"><gtr:id>A4B75635-B5CA-4813-867C-E1A3FF17C446</gtr:id><gtr:firstName>Bazbek</gtr:firstName><gtr:surname>Davletov</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105178791"><gtr:id>877D45C8-1DB7-4537-A216-2FF64D10E949</gtr:id><gtr:title>Regulation of calcium-triggered vesicle fusion</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105178791</gtr:grantReference><gtr:abstractText>Release of neurotransmitters and hormones is fine-tuned in our bodies and abnormalities in this process can lead to various neurological and endocrine disorders. Neurotransmitters and hormones are released when secretory vesicles fuse with the plasma membrane in a tightly regulated manner. We investigate proteins and lipids involved in vesicle fusion, in order to uncover the precise molecular principles that govern secretion. We demonstrated that omega fatty acids and a natural lipid called sphingosine stimulate protein assembly leading to increased vesicle fusion. We used one of the proteins we work with to develop a novel contrast agent for the detection of tumours in vivo and now plan to exploit other proteins for medicinal uses. We are working on improving botulinum neurotoxin and other modular toxins for medicinal use: by retargeting them to required tissues and by making their safer-to-use versions. We are continuing investigation of how lipidic molecules and related drugs can affect protein functions and thus regulate vesicle fusion. Elucidation of the molecular pathway operating in neurotransmitter and hormone release will contribute to our understanding of brain function and also to treatments of neurodegenerative and phsychiatric disorders.</gtr:abstractText><gtr:technicalSummary>Regulated calcium-triggered neurotransmitter and hormone release controls every aspect of the human body. Hormones and transmitters are normally stored in secretory vesicles which must fuse with the cell plasma membrane for release to occur. In brain, neuromuscular junctions and endocrine organs, a set of three SNARE proteins plays the central role in accomplishing fusion of vesicular and plasma membranes: syntaxin, SNAP-25 and synaptobrevin. It is generally accepted that these three proteins, normally resident in the two opposing membranes, engage each other and form an extremely tight SNARE complex. Formation of this complex drives fusion of two membranes, leading to release of the vesicular cargo molecules into the extra-cellular space. It became clear that the comprehensive description of regulatory mechanisms governing the SNARE assembly pathway will lead to an understanding of the regulation of neurotransmitter and hormone release. Deciphering regulatory protein-protein and protein-lipid interactions that govern the membrane fusion requires rigorous study on a molecular level. By investigating SNARE proteins, both in solution and in a membrane environment, we uncovered the vesicular restriction of synaptobrevin as the likely basis for the tight control of neurotransmitter and hormone release. We demonstrated that a common lipid - sphingosine ? can both activate synaptobrevin and facilitate neurotransmitter and hormone release. We also uncovered a positive role of omega-3 and omega-6 fatty acids in driving formation of syntaxin/SNAP-25 heterodimer. Our work has shed light on the molecular mechanism underlying the difference in duration of neuromuscular paralysis caused by botulinum toxins A and E. 

We used synaptotagmin?s properties to develop a novel contrast agent for the detection of tumours in vivo and plan to exploit SNARE proteins for medicinal uses. We are working on improving botulinum neurotoxins and other modular toxins for clinical use: retargeting them to heterologous cell types and making their safer versions. We are continuing investigation of how lipids affect SNARE proteins and thus regulate neurotransmitter and hormone release.

References:
2012 Raingo J, Khvotchev M, Liu P, Darios F, Li YC, Ramirez DM, Adachi M, Lemieux P, Toth K, Davletov B, Kavalali ET. ?VAMP4 directs synaptic vesicles to a pool that selectively maintains asynchronous neurotransmission? Nat Neurosci. Epub ahead of print doi: 10.1038/nn.3067

Ferrari E, Soloviev M, Niranjan D, Arsenault J, Gu C, Vallis Y, O'Brien J, Davletov B. ?Assembly of protein building blocks using a short synthetic Peptide? Bioconjug Chem. 23:479-84
2011 Ferrari E, Maywood E, Restani L, Caleo M, Pirazzini M, Rossetto O, Hastings M, Niranjan D, Schiavo G, Davletov B. ?Re-assembled botulinum neurotoxin inhibits CNS functions without systemic toxicity? Toxins, 3, 345-55
2010 Darios F, Niranjan D, Ferrari E, Zhang F, Soloviev M, Rummel A, Bigalke H, Suckling J, Ushkaryov Y, Naumenko N, Shakirzyanova A, Giniatullin R, Maywood E, Hastings M, Binz T, Davletov B. ?SNARE tagging allows step-wise assembly of a multimodular medicinal toxin? Proc Nat Acad Sci USA 107, 18197-201</gtr:technicalSummary><gtr:fund><gtr:end>2012-09-03</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>3065027</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute of Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Developing an imaging agent for tumour treatments</gtr:description><gtr:id>B8057313-7836-4757-ABA5-7DA131983D61</gtr:id><gtr:impact>18187402 17998093 17411099</gtr:impact><gtr:outcomeId>BFB81400201-1</gtr:outcomeId><gtr:partnerContribution>Several joint publications describing the new imaging agent.</gtr:partnerContribution><gtr:piContribution>I gave the original idea and supplied the C2 protein and DNA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>New non-paralytic botulinum molecules for the control of pain</gtr:description><gtr:id>692E15E4-A275-4849-8531-370C4A9F3A7F</gtr:id><gtr:impact>Synthetic self-assembling clostridial chimera for modulation of sensory functions.


Ferrari E, Gu C, Niranjan D, Restani L, Rasetti-Escargueil C, Obara I, Geranton SM, Arsenault J, Goetze TA, Harper CB, Nguyen TH, Maywood E, O'Brien J, Schiavo G, Wheeler DW, Meunier FA, Hastings M, Edwardson JM, Sesardic D, Caleo M, Hunt SP, Davletov B.

Bioconjug Chem. 2013 Oct 16;24(10):1750-9. doi: 10.1021/bc4003103. Epub 2013 Sep 20.</gtr:impact><gtr:outcomeId>nSLfTKASUnH-1</gtr:outcomeId><gtr:partnerContribution>My team engineer new analgesic drugs while the UCL team tests them in established animal models</gtr:partnerContribution><gtr:piContribution>My team engineer new analgesic drugs while the UCL team tests them in established animal models</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Developing long-lasting pain relief</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8AE2B3A1-BB7E-4F0C-8C7D-49F409D166E3</gtr:id><gtr:impact>Many worldwide agencies distributed the news about our new non-paralysing botulinum molecule as a potential long-lasting pain relief

People suffering from chronic pain contacted me asking to be volunteers for the new pain relief</gtr:impact><gtr:outcomeId>YbMzo1y6WFQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.dailymail.co.uk/news/article-2479300/Botox-jab-ease-arthritis-cancer-effects.html</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>What we know about the Brain</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>19D0D635-DC5F-47BA-8128-5FF22A35497F</gtr:id><gtr:impact>Powerpoint presentation on synaptic function in brain

school children interest in brain research</gtr:impact><gtr:outcomeId>78A78AB3D18</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scientists find way to refine Botox for new uses | Reuters</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CA7CFE21-39D5-4C54-9652-2445BFB9EF5F</gtr:id><gtr:impact>Reuters story about our new non-paralytic BOTOX was published in many newspapers around the world and on numerous internet sites.

Many medical doctors placed this story on their website to highlight safe features of botulinum neurotoxin.</gtr:impact><gtr:outcomeId>jUKGjL6LkHJ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>99946</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant (VR)</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>Parkinson's UK</gtr:fundingOrg><gtr:id>48A40288-08FC-4CB7-8D02-42D6BC8CA452</gtr:id><gtr:outcomeId>0E5B2198D8F0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRCT Development Gap Funding (CG)</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>MRC Technology (MRCT)</gtr:fundingOrg><gtr:id>A4D6D545-A2A4-4932-B33F-98807DD08C19</gtr:id><gtr:outcomeId>VNAFS2cZ3vt0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>685853</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Neuroscience and Mental Health Board grant</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K022539/1</gtr:fundingRef><gtr:id>7423259C-D58C-47CB-BE83-EE78DFEB0E27</gtr:id><gtr:outcomeId>bHm7p7nTKXN</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000</gtr:amountPounds><gtr:country>Spain, Kingdom of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Leonardo Da Vinci student grant</gtr:description><gtr:end>2008-12-02</gtr:end><gtr:fundingOrg>University of Leon</gtr:fundingOrg><gtr:id>065F4C32-C726-4F47-946E-F0001EF9EE45</gtr:id><gtr:outcomeId>28D2219FDA40</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>83891</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2007-12-02</gtr:end><gtr:fundingOrg>Parkinson's UK</gtr:fundingOrg><gtr:id>0025C2FD-70BB-448D-86AA-10C747147AA9</gtr:id><gtr:outcomeId>ETYGY82NDay0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UK/US Collaborative Initiative in Bioscience</gtr:description><gtr:end>2006-12-02</gtr:end><gtr:fundingOrg>Department for Business, Energy &amp; Industrial Strategy</gtr:fundingOrg><gtr:id>D66F3ACB-6DC7-4E1B-A8F4-D792CBDC24DA</gtr:id><gtr:outcomeId>8BA0DC2861A0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>53067</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRCT Development Gap Funding</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>MRC Technology (MRCT)</gtr:fundingOrg><gtr:id>347F7F52-DED5-42E1-A3AF-F98840ED0A7A</gtr:id><gtr:outcomeId>419F22D72740</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>We developed non-paralysing botulinum molecules for pain relief and also a 'protein stapling' technology</gtr:description><gtr:grantRef>MC_U105178791</gtr:grantRef><gtr:id>72B114AF-74AF-4E61-81DA-F5E986C07F94</gtr:id><gtr:impact>http://www.dailymail.co.uk/news/article-2479300/Botox-jab-ease-arthritis-cancer-effects.html</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>3B01A8BCB9B</gtr:outcomeId><gtr:patentId>WO2011018665</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Complexing system</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>Many techniques in analytical biology, clinical diagnostics and bioindustry rely on binary affinity tags. Current choice of affinity tags is rather limited with biotin-streptavidin system being the market leader due to the irreversible interaction of the small drug-like biotin with the tetrameric protein, streptavidin. Here we report a novel affinity system which utilizes two monomeric polypeptides which can interact in an irreversible manner. This system utilizes the unique stability of the recently discovered tetrahelical coiled-coil complex which is known as the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) protein complex. We achieved the binary system by tandem linking of the SNARE coiled coils. As a proof of principle we demonstrate that a recombinant enzyme expressed in bacteria, glutathione S-transferase, can be quickly and permanently immobilized on a gel matrix in a single step starting with the bacterial detergent extract. Our non-covalent, site-directed and yet irreversible immobilization of the enzyme preserves the activity of the immobilized enzyme and may be used as a convenient alternative to the streptavidin-biotin system or chemical linking.</gtr:description><gtr:id>82A5D6F1-C221-42AD-A10C-AE78080F9E86</gtr:id><gtr:impact>manuscript submitted for publication</gtr:impact><gtr:outcomeId>EF242FC37BA</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Tetrahelical Combinatorial Scaffold (TetriCS)</gtr:title><gtr:type>Support Tool - For Fundamental Research</gtr:type><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Neuronal SNARE proteins were turned into a binary affinity system</gtr:description><gtr:id>E6434EF8-3640-4CD3-8B50-C99F9E34266A</gtr:id><gtr:impact>Paper published in J Nanobiotechnology</gtr:impact><gtr:outcomeId>38BA9F0586B</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Complexing system</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Botulinum neurotoxin which blocks central neurons but doesn't cause peripheral paralysis</gtr:description><gtr:id>0F612376-F076-430A-B915-3BC8C9B7C64B</gtr:id><gtr:impact>Publication and MRC Technology grant to develop anti-pain medicines</gtr:impact><gtr:outcomeId>QzYEEfXRTMP</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Non-paralytic BOTOX</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9D76E61C-9BB7-4C07-8DE6-9C81A8EC84A3</gtr:id><gtr:title>Binary polypeptide system for permanent and oriented protein immobilization.</gtr:title><gtr:parentPublicationTitle>Journal of nanobiotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d25e20ab73df3cd17093cc62058b2e1f"><gtr:id>d25e20ab73df3cd17093cc62058b2e1f</gtr:id><gtr:otherNames>Ferrari E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1477-3155</gtr:issn><gtr:outcomeId>acHN63H6MnC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E43A748-A8A2-4055-A592-F306A7D012B8</gtr:id><gtr:title>Detection of cell death in tumors by using MR imaging and a gadolinium-based targeted contrast agent.</gtr:title><gtr:parentPublicationTitle>Radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e009c100a5f52795f9036d0b16d9b59b"><gtr:id>e009c100a5f52795f9036d0b16d9b59b</gtr:id><gtr:otherNames>Krishnan AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0033-8419</gtr:issn><gtr:outcomeId>AD68FA3B0EE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8534730-15C8-48E6-B199-664B4283BA69</gtr:id><gtr:title>The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92f48b1fb7ba786aae2c8f6b7e7aa88d"><gtr:id>92f48b1fb7ba786aae2c8f6b7e7aa88d</gtr:id><gtr:otherNames>Mahrhold S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>62FDA23F6AF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>340FD755-379E-435D-A1F7-2EACB40C7202</gtr:id><gtr:title>Real-time assay for monitoring membrane association of lipid-binding domains.</gtr:title><gtr:parentPublicationTitle>Analytical biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44ed680d1be048d6f4f4ffc3f55daec3"><gtr:id>44ed680d1be048d6f4f4ffc3f55daec3</gtr:id><gtr:otherNames>Connell E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0003-2697</gtr:issn><gtr:outcomeId>13904F88052</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FE0DB57-4570-4BE0-AAFA-11D79E06EA42</gtr:id><gtr:title>Lipid metabolites enhance secretion acting on SNARE microdomains and altering the extent and kinetics of single release events in bovine adrenal chromaffin cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32e43c8bd7bd9a6a3a02f0115fca3ade"><gtr:id>32e43c8bd7bd9a6a3a02f0115fca3ade</gtr:id><gtr:otherNames>Garc?a-Mart?nez V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14125_25_24073281</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA793DB9-77C5-44F9-95B1-4EF0C20DCFBC</gtr:id><gtr:title>N-terminal acetylation of the neuronal protein SNAP-25 is revealed by the SMI81 monoclonal antibody.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44ed680d1be048d6f4f4ffc3f55daec3"><gtr:id>44ed680d1be048d6f4f4ffc3f55daec3</gtr:id><gtr:otherNames>Connell E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>pm_14125_15_19747004</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28A38763-E109-4C4F-B25B-21AD34308993</gtr:id><gtr:title>Munc18-1 is critical for plasma membrane localization of syntaxin1 but not of SNAP-25 in PC12 cells.</gtr:title><gtr:parentPublicationTitle>Molecular biology of the cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a9dd600b52b61c6973d1a30943499f1"><gtr:id>1a9dd600b52b61c6973d1a30943499f1</gtr:id><gtr:otherNames>Arunachalam L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1059-1524</gtr:issn><gtr:outcomeId>409B2A7AD2F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3AB144B-CCAE-4BA9-9E8D-2A355B6C573E</gtr:id><gtr:title>Unexpected transcellular protein crossover occurs during canonical DNA transfection.</gtr:title><gtr:parentPublicationTitle>Journal of cellular biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1d01316e35afbae3f445e49a4e2febb"><gtr:id>c1d01316e35afbae3f445e49a4e2febb</gtr:id><gtr:otherNames>Arsenault J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0730-2312</gtr:issn><gtr:outcomeId>545b94b381cb89.35459464</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A146805-741D-411C-826B-9811CDE3688F</gtr:id><gtr:title>Control of autophagosome axonal retrograde flux by presynaptic activity unveiled using botulinum neurotoxin type a.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ee1bcb1cf299cd91d287356fafa8cc8"><gtr:id>9ee1bcb1cf299cd91d287356fafa8cc8</gtr:id><gtr:otherNames>Wang T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>56cf1b701e8370.39697203</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>778225FD-CD09-48EC-AC4A-E6C4D99FDF88</gtr:id><gtr:title>Stapling of the botulinum type A protease to growth factors and neuropeptides allows selective targeting of neuroendocrine cells.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1d01316e35afbae3f445e49a4e2febb"><gtr:id>c1d01316e35afbae3f445e49a4e2febb</gtr:id><gtr:otherNames>Arsenault J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>pm_14125_25_23638840</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA966048-3E9C-4623-88D2-02FE23FBB01D</gtr:id><gtr:title>VAMP4 directs synaptic vesicles to a pool that selectively maintains asynchronous neurotransmission.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fb48242000c4d2e1972852996eb6849"><gtr:id>9fb48242000c4d2e1972852996eb6849</gtr:id><gtr:otherNames>Raingo J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>pm_14125_25_22406549</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52308026-A1E0-454F-A226-146B18FAA30B</gtr:id><gtr:title>Synthetic self-assembling clostridial chimera for modulation of sensory functions.</gtr:title><gtr:parentPublicationTitle>Bioconjugate chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d25e20ab73df3cd17093cc62058b2e1f"><gtr:id>d25e20ab73df3cd17093cc62058b2e1f</gtr:id><gtr:otherNames>Ferrari E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1043-1802</gtr:issn><gtr:outcomeId>pm_14125_25_24011174</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3419877B-5DC8-477A-B455-CC7A69333BC4</gtr:id><gtr:title>Botulinum protease-cleaved SNARE fragments induce cytotoxicity in neuroblastoma cells.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1d01316e35afbae3f445e49a4e2febb"><gtr:id>c1d01316e35afbae3f445e49a4e2febb</gtr:id><gtr:otherNames>Arsenault J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>545b9457d87ad7.44859546</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B728CE7E-D0FD-4B1D-B89F-A82E58D51453</gtr:id><gtr:title>Cortical spreading depression induces oxidative stress in the trigeminal nociceptive system.</gtr:title><gtr:parentPublicationTitle>Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97b62ca4e3af418d9f05373dcc0c62fe"><gtr:id>97b62ca4e3af418d9f05373dcc0c62fe</gtr:id><gtr:otherNames>Shatillo A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0306-4522</gtr:issn><gtr:outcomeId>pm_14125_25_24036374</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F6C5ECC-E280-4CF7-AEB7-D55CC1010AF7</gtr:id><gtr:title>SPECT imaging of myocardial infarction using 99mTc-labeled C2A domain of synaptotagmin I in a porcine ischemia-reperfusion model.</gtr:title><gtr:parentPublicationTitle>Nuclear medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3ed41383f1ea39d4fa25fe1fdc6a5c7"><gtr:id>c3ed41383f1ea39d4fa25fe1fdc6a5c7</gtr:id><gtr:otherNames>Fang W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0969-8051</gtr:issn><gtr:outcomeId>62708FDCA8B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AD13702-4CCA-49DC-848C-1831736CA4EB</gtr:id><gtr:title>Synaptotagmin interaction with SNAP-25 governs vesicle docking, priming, and fusion triggering.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c42525e09acc0f1d59ac8b1f61bdc908"><gtr:id>c42525e09acc0f1d59ac8b1f61bdc908</gtr:id><gtr:otherNames>Mohrmann R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>pm_14125_25_24005294</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCCE1E3F-0704-4FEC-B32E-AA522FFC7CF6</gtr:id><gtr:title>Sphingomimetic multiple sclerosis drug FTY720 activates vesicular synaptobrevin and augments neuroendocrine secretion.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3761f18c7bb80a2cff40dc91e5b460b8"><gtr:id>3761f18c7bb80a2cff40dc91e5b460b8</gtr:id><gtr:otherNames>Darios FD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a82bb6eb01960.69671461</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB582D92-DEAA-4755-8C2B-10CAF34A2870</gtr:id><gtr:title>Re-assembled botulinum neurotoxin inhibits CNS functions without systemic toxicity.</gtr:title><gtr:parentPublicationTitle>Toxins</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d25e20ab73df3cd17093cc62058b2e1f"><gtr:id>d25e20ab73df3cd17093cc62058b2e1f</gtr:id><gtr:otherNames>Ferrari E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2072-6651</gtr:issn><gtr:outcomeId>bSKCwVFANXx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D382618-0E51-46C2-BC9A-0DE4566C19B1</gtr:id><gtr:title>Fingolimod--a sphingosine-like molecule inhibits vesicle mobility and secretion in astrocytes.</gtr:title><gtr:parentPublicationTitle>Glia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e8803413251d8f261ae51e55e5c2b51"><gtr:id>7e8803413251d8f261ae51e55e5c2b51</gtr:id><gtr:otherNames>Trkov S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn><gtr:outcomeId>pm_14125_25_22639011</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D3F9F58-E132-4B90-8A2C-43E40942AF7F</gtr:id><gtr:title>Alpha-synuclein, lipids and Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Progress in lipid research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1604c1ce5b8f03359d661530b2412dcb"><gtr:id>1604c1ce5b8f03359d661530b2412dcb</gtr:id><gtr:otherNames>Ruip?rez V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0163-7827</gtr:issn><gtr:outcomeId>pm_14125_25_20580911</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F197572-7412-4A15-8B48-0D4BE1CAA841</gtr:id><gtr:title>Cross-linking of phospholipid membranes is a conserved property of calcium-sensitive synaptotagmins.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44ed680d1be048d6f4f4ffc3f55daec3"><gtr:id>44ed680d1be048d6f4f4ffc3f55daec3</gtr:id><gtr:otherNames>Connell E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>ED22B39A33C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>822A9B25-7143-4908-984E-38773588BA1A</gtr:id><gtr:title>Conserved prefusion protein assembly in regulated exocytosis.</gtr:title><gtr:parentPublicationTitle>Molecular biology of the cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c53e8f78e9f0459235e86f9fb34f1f5"><gtr:id>3c53e8f78e9f0459235e86f9fb34f1f5</gtr:id><gtr:otherNames>Rickman C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1059-1524</gtr:issn><gtr:outcomeId>CCA2980AEB0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC222236-5AA9-4C84-A7F5-E55E9D07579D</gtr:id><gtr:title>SNAP25 is a pre-synaptic target for the depressant action of reactive oxygen species on transmitter release.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f0fc8696164eb0e62b00d3448ef276d"><gtr:id>4f0fc8696164eb0e62b00d3448ef276d</gtr:id><gtr:otherNames>Giniatullin AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>8DB2A961B55</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E04AC95-2AB7-4FC2-A7D4-2C9E44C50211</gtr:id><gtr:title>Lipid function at synapses.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc557bc312a085ddea41a9a0ec865646"><gtr:id>bc557bc312a085ddea41a9a0ec865646</gtr:id><gtr:otherNames>Davletov B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-4388</gtr:issn><gtr:outcomeId>pm_14125_25_20655194</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC3BEDBA-AA94-481B-AA1E-7112B1490A65</gtr:id><gtr:title>DOC2B acts as a calcium switch and enhances vesicle fusion.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fcdd05e676df22adcd937604aee33657"><gtr:id>fcdd05e676df22adcd937604aee33657</gtr:id><gtr:otherNames>Friedrich R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>89676531CF3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F0E3287-0003-4F43-8ACE-0F5E66BB2B97</gtr:id><gtr:title>A paramagnetic nanoprobe to detect tumor cell death using magnetic resonance imaging.</gtr:title><gtr:parentPublicationTitle>Nano letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f5d94ca7edb3fb42619bb1cce60efe5"><gtr:id>8f5d94ca7edb3fb42619bb1cce60efe5</gtr:id><gtr:otherNames>Neves AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1530-6984</gtr:issn><gtr:outcomeId>A3D1791B1CC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A241706B-26EB-4013-A597-6C30EE444B12</gtr:id><gtr:title>Alpha-synuclein sequesters arachidonic acid to modulate SNARE-mediated exocytosis.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f05609fae12cc4ff409298eb050288e9"><gtr:id>f05609fae12cc4ff409298eb050288e9</gtr:id><gtr:otherNames>Darios F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>PkD4s63tTTt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>846CA819-5A3F-4955-AECB-00CC2619E337</gtr:id><gtr:title>Neurexin Ibeta and neuroligin are localized on opposite membranes in mature central synapses.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc7dd64751e1e8cd967dac13dd6884c6"><gtr:id>bc7dd64751e1e8cd967dac13dd6884c6</gtr:id><gtr:otherNames>Berninghausen O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>3A9A3E875F7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>735DF4C4-CF13-419F-A3CB-1796F1D1012F</gtr:id><gtr:title>Presynaptic neurotoxins: an expanding array of natural and modified molecules.</gtr:title><gtr:parentPublicationTitle>Cell calcium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc557bc312a085ddea41a9a0ec865646"><gtr:id>bc557bc312a085ddea41a9a0ec865646</gtr:id><gtr:otherNames>Davletov B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0143-4160</gtr:issn><gtr:outcomeId>pm_14125_25_22658826</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB28963B-CF87-4FE6-ACCB-31AE2F86CD4D</gtr:id><gtr:title>Beta-strand recombination in tricalbin evolution and the origin of synaptotagmin-like C2 domains.</gtr:title><gtr:parentPublicationTitle>Proteins</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e428e703175921344f21d723e41956c6"><gtr:id>e428e703175921344f21d723e41956c6</gtr:id><gtr:otherNames>Jim?nez JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0887-3585</gtr:issn><gtr:outcomeId>D4BF5C55E29</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD66777D-EE53-4A7F-BDEC-9B21C1F289BB</gtr:id><gtr:title>Alpha-synuclein adopts an alpha-helical conformation in the presence of polyunsaturated fatty acids to hinder micelle formation.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6616999c2cbf7228fb59c9ead8bbaa54"><gtr:id>6616999c2cbf7228fb59c9ead8bbaa54</gtr:id><gtr:otherNames>Broersen K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>D0876D47179</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>084ADF35-99C8-4195-B450-4C616501ACDF</gtr:id><gtr:title>Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f05609fae12cc4ff409298eb050288e9"><gtr:id>f05609fae12cc4ff409298eb050288e9</gtr:id><gtr:otherNames>Darios F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>D5D091D0CF6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C73443F4-38CE-4C62-B6AF-C4B57AEABBDA</gtr:id><gtr:title>Lipid-protein interactions in exocytotic release of hormones and neurotransmitters</gtr:title><gtr:parentPublicationTitle>Clinical Lipidology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39c44f65fc5dc92a730cb63759864f6a"><gtr:id>39c44f65fc5dc92a730cb63759864f6a</gtr:id><gtr:otherNames>Rituper B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>Kzy4eXJyZQW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBD08F0E-B809-4E19-A56C-56665620EB99</gtr:id><gtr:title>Two complementary approaches for intracellular delivery of exogenous enzymes.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02170e5ce86f76cccf072177ac3dfe11"><gtr:id>02170e5ce86f76cccf072177ac3dfe11</gtr:id><gtr:otherNames>Rust A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56cf1b6fd75cb5.70749807</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4BF6C71-A166-4A07-A3AB-037DA258E04E</gtr:id><gtr:title>Sphingosine facilitates SNARE complex assembly and activates synaptic vesicle exocytosis.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f05609fae12cc4ff409298eb050288e9"><gtr:id>f05609fae12cc4ff409298eb050288e9</gtr:id><gtr:otherNames>Darios F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>189D20746EF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C813A171-BEAC-4E4D-B014-A54DB2996861</gtr:id><gtr:title>Regulation of SNARE fusion machinery by fatty acids.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc557bc312a085ddea41a9a0ec865646"><gtr:id>bc557bc312a085ddea41a9a0ec865646</gtr:id><gtr:otherNames>Davletov B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>084E5FCA6C4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BBA902F-B8B8-4115-8DDE-E8DF1AC3AFE4</gtr:id><gtr:title>A multiple sclerosis drug sheds light on astrocyte biology.</gtr:title><gtr:parentPublicationTitle>Acta physiologica (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc557bc312a085ddea41a9a0ec865646"><gtr:id>bc557bc312a085ddea41a9a0ec865646</gtr:id><gtr:otherNames>Davletov B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1748-1708</gtr:issn><gtr:outcomeId>545b94580cf4e0.71160914</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DB65264-01B1-4FE8-A42C-678074EBA99A</gtr:id><gtr:title>Synaptic vesicle docking: sphingosine regulates syntaxin1 interaction with Munc18.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/130db4f3017b92f29b80dab8c1caef9a"><gtr:id>130db4f3017b92f29b80dab8c1caef9a</gtr:id><gtr:otherNames>Camoletto PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>8746FC593D4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EBF5590-EE19-4595-9F80-FF8B065ACC20</gtr:id><gtr:title>SNARE Proteins</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d26e1e824111569b3e1a5904ef80836"><gtr:id>6d26e1e824111569b3e1a5904ef80836</gtr:id><gtr:otherNames>Connell Emma</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:outcomeId>pnQfMGCnk8b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E0EAE03-4D22-43ED-9B48-592CA29ACDDD</gtr:id><gtr:title>Tight coupling of the t-SNARE and calcium channel microdomains in adrenomedullary slices and not in cultured chromaffin cells.</gtr:title><gtr:parentPublicationTitle>Cell calcium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9ce2af052c15d01d8f0e3e971ae8c52"><gtr:id>e9ce2af052c15d01d8f0e3e971ae8c52</gtr:id><gtr:otherNames>Lopez I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0143-4160</gtr:issn><gtr:outcomeId>6C28D9E580C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>141F806F-DE1F-4808-B87B-650B38969BF2</gtr:id><gtr:title>Mechanism of arachidonic acid action on syntaxin-Munc18.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44ed680d1be048d6f4f4ffc3f55daec3"><gtr:id>44ed680d1be048d6f4f4ffc3f55daec3</gtr:id><gtr:otherNames>Connell E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>FFD859D36FB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42D3053F-6025-4854-9E9E-00DBDE08D9C0</gtr:id><gtr:title>Synuclein proteins of the pufferfish Fugu rubripes: sequences and functional characterization.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f180a15663e642d6e2c71c1a59a300b"><gtr:id>8f180a15663e642d6e2c71c1a59a300b</gtr:id><gtr:otherNames>Yoshida H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>4E5EBC5E3E8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E419095-C385-41F0-A277-867817C2DDF2</gtr:id><gtr:title>SNARE tagging allows stepwise assembly of a multimodular medicinal toxin.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f05609fae12cc4ff409298eb050288e9"><gtr:id>f05609fae12cc4ff409298eb050288e9</gtr:id><gtr:otherNames>Darios F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>ZkQNWC3QWdG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4510279-494F-4192-99DC-BE04FCA9E6B1</gtr:id><gtr:title>Phospholipases and fatty acid signalling in exocytosis.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f05609fae12cc4ff409298eb050288e9"><gtr:id>f05609fae12cc4ff409298eb050288e9</gtr:id><gtr:otherNames>Darios F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>670EFCD41A8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D89A7A95-8925-4667-AC51-9E30EEBB4E63</gtr:id><gtr:title>Assembly of protein building blocks using a short synthetic peptide.</gtr:title><gtr:parentPublicationTitle>Bioconjugate chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d25e20ab73df3cd17093cc62058b2e1f"><gtr:id>d25e20ab73df3cd17093cc62058b2e1f</gtr:id><gtr:otherNames>Ferrari E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1043-1802</gtr:issn><gtr:outcomeId>pm_14125_25_22299630</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105178791</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>